AI
DBVT

Atria Investments’s DBV Technologies DBVT Stock Holding History

Atria Investments’s Portfolio DBVT Stock Details DBVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$442K Buy
+21,135
New +$441K ﹤0.01% 1513

Other funds holding DBVT

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Atria Investments's DBVT Position: Q1 2026 in Review

Atria Investments opened a new position in DBV Technologies (DBVT) in Q1 2026: 21,135 shares worth $442K. The stake represents ﹤0.01% of the portfolio and ranks #1513 among its holdings.

71 funds tracked by Wall St. Rank hold DBVT as of Q1 2026.

  • Atria Investments held 21,135 shares of DBV Technologies worth $442K as of Q1 2026.
  • DBV Technologies was a new Atria Investments position in Q1 2026.
  • DBV Technologies made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1513 holding.
  • 71 funds tracked by Wall St. Rank held DBV Technologies as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.